Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04494425 |
|---|---|
| Brief Title: | Study of Trastuzumab Deruxtecan (T-DXd) vs Investigator's Choice Chemotherapy in HER2-low, Hormone Receptor Positive, Metastatic Breast Cancer (DB-06) |
| First Submitted : | July 20, 2020 |
| First Submitted that Met QC Criteria : | July 28, 2020 |
| First Posted : | July 31, 2020 |
| Last Update Submitted that Met QC Criteria : | April 11, 2024 |
| Last Update Posted : | April 12, 2024 |